Back

Multimodal single cell analysis of the paediatric lower airway reveals novel immune cell phenotypes in early life health and disease

Maksimovic, J.; Shanthikumar, S.; Howitt, G.; Hickey, P. F.; Ho, W.; Anttila, C.; Brown, D. V.; Senabouth, A.; Kaczorowski, D.; Amann-Zalcenstein, D.; Powell, J. E.; Ranganathan, S.; Oshlack, A.; Neeland, M. R.

2022-06-17 systems biology
10.1101/2022.06.17.496207 bioRxiv
Show abstract

Inflammation is a key driver of cystic fibrosis (CF) lung disease, not addressed by current standard care. Improved understanding of the mechanisms leading to aberrant inflammation may assist the development of effective anti-inflammatory therapy. Single-cell RNA sequencing (scRNA-seq) allows profiling of cell composition and function at previously unprecedented resolution. Herein, we seek to use multimodal single-cell analysis to comprehensively define immune cell phenotypes, proportions and functional characteristics in preschool children with CF. We analyzed 42,658 cells from bronchoalveolar lavage of 11 preschool children with CF and a healthy control using scRNA-seq and parallel assessment of 154 cell surface proteins. Validation of cell types identified by scRNA-seq was achieved by assessment of samples by spectral flow cytometry. Analysis of transcriptome expression and cell surface protein expression, combined with functional pathway analysis, revealed 41 immune and epithelial cell populations in BAL. Spectral flow cytometry analysis of over 256,000 cells from a subset of the same patients revealed high correlation in major cell type proportions across the two technologies. Macrophages consisted of 13 functionally distinct sub populations, including previously undescribed populations enriched for markers of vesicle production and regulatory/repair functions. Other novel cell populations included CD4 T cells expressing inflammatory IFN/{beta} and NF{kappa}B signalling genes. Our work provides a comprehensive cellular analysis of the pediatric lower airway in preschool children with CF, reveals novel cell types and provides a reference for investigation of inflammation in early life CF.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
American Journal of Respiratory Cell and Molecular Biology
38 papers in training set
Top 0.1%
43.7%
2
JCI Insight
241 papers in training set
Top 0.4%
6.7%
50% of probability mass above
3
American Journal of Respiratory and Critical Care Medicine
39 papers in training set
Top 0.1%
6.6%
4
Journal of Cystic Fibrosis
15 papers in training set
Top 0.1%
4.8%
5
American Journal of Physiology-Lung Cellular and Molecular Physiology
39 papers in training set
Top 0.1%
4.5%
6
Nature Communications
4913 papers in training set
Top 45%
2.5%
7
Scientific Reports
3102 papers in training set
Top 48%
2.2%
8
Cell Reports Methods
141 papers in training set
Top 2%
2.0%
9
npj Genomic Medicine
33 papers in training set
Top 0.3%
1.8%
10
Genome Medicine
154 papers in training set
Top 4%
1.8%
11
iScience
1063 papers in training set
Top 17%
1.6%
12
Disease Models & Mechanisms
119 papers in training set
Top 1%
1.6%
13
European Respiratory Journal
54 papers in training set
Top 1%
1.4%
14
Life Science Alliance
263 papers in training set
Top 0.5%
1.4%
15
Molecular Therapy - Nucleic Acids
24 papers in training set
Top 0.2%
1.3%
16
Cell Reports Medicine
140 papers in training set
Top 6%
1.0%
17
Nature Medicine
117 papers in training set
Top 4%
0.9%
18
Cell Stem Cell
57 papers in training set
Top 2%
0.8%
19
Nature Immunology
71 papers in training set
Top 2%
0.8%
20
Molecular Therapy
71 papers in training set
Top 3%
0.7%
21
Pediatric Pulmonology
14 papers in training set
Top 0.4%
0.7%
22
The Journal of Infectious Diseases
182 papers in training set
Top 6%
0.7%
23
International Journal of Molecular Sciences
453 papers in training set
Top 17%
0.7%
24
Cell Reports
1338 papers in training set
Top 36%
0.5%
25
Immunity
58 papers in training set
Top 5%
0.5%
26
Circulation: Genomic and Precision Medicine
42 papers in training set
Top 1%
0.5%